Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912361768> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2912361768 abstract "Background: Central retinal artery occlusion (CRAO) results in sudden, painless loss of vision in the affected eye which is usually permanent. Despite 150 years of research, there is no treatment which has been proven to be effective to salvage visual acuity. Acute CRAO may also be amenable to treatment with intravenous tissue plasminogen activator (tPA). In the current work, we evaluated the efficacy of intravenous tPA in an ongoing prospective cohort study. Methods: We enrolled 107 patients with acute CRAO within 48 hours of symptoms onset and with a visual acuity of less than 20/200 from January 2009 until now. Those within 6 hours of onset were offered treatment with tPA; this interval was narrowed to 4.5 hours in July 2015 in response to new data. The primary outcomes were safety and functional visual acuity recovery defined as a final visual acuity of 20/100 or better. Results: Twenty-two patients (20.5% of the cohort) were treated with tPA. One patient had an asymptomatic intracerebral hemorrhage after tPA treatment and there were no other adverse events. Thirty-six percent of tPA-treated patients had recovery of visual acuity when treated within 4.5 hours while only 12.5% of patients who were not treated with tPA had recovery of visual acuity (p=0.009). None of the patients treated with tPA between 4.5 and 6 hours after onset (0/8) recovered. The median time to arrival in the ER after onset of symptoms for all patients with acute CRAO was 8.0 hrs (IQR 5.5 to 23), but the median time to initial contact with any provider was 3.9 hrs after onset (IQR 2.0 to 12) meaning a significant fraction of patients with acute CRAO may be candidates for fibrinolysis if they are efficiently routed to emergency departments. Finally we incorporated our results and those of several other recent cohort studies into an updated subject-level meta-analysis to estimate the effect-size of tPA treatment on visual acuity across a broader population and demonstrate the reproducibility of our findings. Conclusions: This study showed that visual outcomes for acute CRAO are greatly improved with tPA treatment and this treatment can be feasibly applied to a high percentage of affected patients. The results of our study strongly support proceeding to a clinical trial." @default.
- W2912361768 created "2019-02-21" @default.
- W2912361768 creator A5018338106 @default.
- W2912361768 creator A5026164013 @default.
- W2912361768 creator A5026670708 @default.
- W2912361768 creator A5042517107 @default.
- W2912361768 creator A5073498622 @default.
- W2912361768 creator A5083967951 @default.
- W2912361768 date "2019-02-01" @default.
- W2912361768 modified "2023-09-26" @default.
- W2912361768 title "Abstract TMP90: Advances in Treatment of Central Retinal Artery Occlusion: Potential Efficacy of Systemic Fibrinolysis" @default.
- W2912361768 doi "https://doi.org/10.1161/str.50.suppl_1.tmp90" @default.
- W2912361768 hasPublicationYear "2019" @default.
- W2912361768 type Work @default.
- W2912361768 sameAs 2912361768 @default.
- W2912361768 citedByCount "0" @default.
- W2912361768 crossrefType "journal-article" @default.
- W2912361768 hasAuthorship W2912361768A5018338106 @default.
- W2912361768 hasAuthorship W2912361768A5026164013 @default.
- W2912361768 hasAuthorship W2912361768A5026670708 @default.
- W2912361768 hasAuthorship W2912361768A5042517107 @default.
- W2912361768 hasAuthorship W2912361768A5073498622 @default.
- W2912361768 hasAuthorship W2912361768A5083967951 @default.
- W2912361768 hasConcept C118487528 @default.
- W2912361768 hasConcept C141071460 @default.
- W2912361768 hasConcept C188816634 @default.
- W2912361768 hasConcept C2776449918 @default.
- W2912361768 hasConcept C2777910003 @default.
- W2912361768 hasConcept C2778257484 @default.
- W2912361768 hasConcept C42219234 @default.
- W2912361768 hasConcept C71924100 @default.
- W2912361768 hasConceptScore W2912361768C118487528 @default.
- W2912361768 hasConceptScore W2912361768C141071460 @default.
- W2912361768 hasConceptScore W2912361768C188816634 @default.
- W2912361768 hasConceptScore W2912361768C2776449918 @default.
- W2912361768 hasConceptScore W2912361768C2777910003 @default.
- W2912361768 hasConceptScore W2912361768C2778257484 @default.
- W2912361768 hasConceptScore W2912361768C42219234 @default.
- W2912361768 hasConceptScore W2912361768C71924100 @default.
- W2912361768 hasIssue "Suppl_1" @default.
- W2912361768 hasLocation W29123617681 @default.
- W2912361768 hasOpenAccess W2912361768 @default.
- W2912361768 hasPrimaryLocation W29123617681 @default.
- W2912361768 hasRelatedWork W1995188757 @default.
- W2912361768 hasRelatedWork W2019324301 @default.
- W2912361768 hasRelatedWork W2057721052 @default.
- W2912361768 hasRelatedWork W2280266936 @default.
- W2912361768 hasRelatedWork W230110346 @default.
- W2912361768 hasRelatedWork W2339147935 @default.
- W2912361768 hasRelatedWork W2423950151 @default.
- W2912361768 hasRelatedWork W2763646354 @default.
- W2912361768 hasRelatedWork W2951286742 @default.
- W2912361768 hasRelatedWork W4309470136 @default.
- W2912361768 hasVolume "50" @default.
- W2912361768 isParatext "false" @default.
- W2912361768 isRetracted "false" @default.
- W2912361768 magId "2912361768" @default.
- W2912361768 workType "article" @default.